Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?

被引：1
|
作者：
Angeli, Fabio [1 ]
Reboldi, Gianpaolo [2 ]
机构：
[1] Hosp SM della Misericordia, Div Cardiol & Cardiovasc Pathophysiol, I-06132 Perugia, Italy
[2] Univ Perugia, Dept Med, I-06132 Perugia, Italy
来源：
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 2015年 / 15卷 / 04期
关键词：
SUBGROUP ANALYSIS; HORIZONS-AMI; HEPARIN; IMPACT; METAANALYSIS; ANGIOPLASTY; INHIBITORS; OUTCOMES; TRIALS;
D O I：
10.1007/s40256-015-0138-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：221 / 224
页数：4
相关论文
共 50 条
  • [1] Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
    Fabio Angeli
    Gianpaolo Reboldi
    American Journal of Cardiovascular Drugs, 2015, 15 : 221 - 224
  • [2] Prolonged bivalirudin infusion post percutaneous coronary intervention and risk of bleeding
    Lombo, Bernardo
    Ibrahim, Homan
    Lievano, Marta
    Diez, Jose
    Fish, David
    CIRCULATION, 2012, 125 (19) : E868 - E868
  • [3] Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding
    Feldman, Alexander
    Suleiman, Khalid
    Bushari, Limor
    Yahalom, Malka
    Rozner, Ehud
    Freedberg, Nahum Adam
    Turgeman, Yoav
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2014, 23 (04) : 227 - 232
  • [4] The impact of bivalirudin on percutaneous coronary intervention-related bleeding
    Lindsey, Jason B.
    Cohen, David J.
    Stolker, Joshua M.
    Mehta, Sameer K.
    Mahoney, Elizabeth
    Robertus, Katherine
    House, John A.
    Kennedy, Kevin
    Riggs, Lisa
    Rao, Sunil V.
    Marso, Steven P.
    EUROINTERVENTION, 2010, 6 (02) : 206 - 213
  • [5] BLEEDING COMPLICATIONS WITH PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF BIVALIRUDIN AND EPTIFIBATIDE
    Kohli, S.
    Campbell, R. J.
    Kjelsberg, M. A.
    Saal, A. K.
    CARDIOLOGY, 2013, 125 : 429 - 429
  • [6] Exploration of bivalirudin use during percutaneous coronary intervention for high bleeding risk patients with chronic total occlusion
    Li, Chenguang
    Ge, Junbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B309 - B309
  • [7] Exploration of Bivalirudin Use during Percutaneous Coronary Intervention for High Bleeding Risk Patients with Chronic Total Occlusion
    Li, Chenguang
    Shen, Yi
    Xu, Rende
    Dai, Yuxiang
    Chang, Shufu
    Lu, Hao
    Ge, Lei
    Ma, Jianying
    Qian, Juying
    Ge, Junbo
    INTERNATIONAL HEART JOURNAL, 2018, 59 (02) : 293 - 299
  • [8] Percutaneous coronary intervention in patients with active bleeding or high bleeding risk
    Nguyen, James
    Nguyen, Thach
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (02): : 165 - 170
  • [9] Bivalirudin in percutaneous coronary intervention
    Caron, MF
    McKendall, GR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (18) : 1841 - 1849
  • [10] Factors influencing the risk of major bleeding with bivalirudin compared with unfractionated heparin in percutaneous coronary intervention
    Mahmoud, Ahmed
    Elgendy, Islam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B88 - B89
12345